Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
Alternative names
Key: ChemomAb Ltd. (1) Acquired (2)
cm-101 (5 trials)
dta-h19 (2 trials)
inodiftagene vixteplasmid (4 trials)
Key: ChemomAb Ltd. (0) Acquired (1)
bacille calmette-guerin (1 trial)
Cholangitis (Phase 2)
Cholangitis, Sclerosing (Phase 2)
Trials (12 total)
Trial APIs (4 total)